hydralazine has been researched along with pituitrin in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (33.33) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dietz, R; Kübler, W; Leinberger, H; Manthey, J; Opherk, D; Osterziel, KJ | 1 |
Chaudhuri, G; Cuevas, JM; Ignarro, LJ; Vargas, HM | 1 |
Graham, RM; Ohanian, J; Shen, YT; Vatner, SF; Young, MA | 1 |
Allen, J; Forman, A; Maigaard, S; Skajaa, K | 1 |
Karasawa, A; Kubo, K; Nakamizo, N; Oka, T; Shuto, K | 1 |
Almazov, VA; Bondarenko, BB; Shabrov, AV | 1 |
Arnstein, MJ; Clough, DP; Major, JS; Oldham, AA | 1 |
Beckett, AH; Frohn, MJ; Jones, GR | 1 |
Hoffman, GE; Schiltz, JC; Stricker, EM; Sved, AF | 1 |
Huang, W; Sjöquist, M; Skott, O; Stricker, EM; Sved, AF | 1 |
Adams, MA; Hale, TM; Heaton, JP; Okabe, H | 1 |
HARDWICK, DF; MISRAHY, GA; STRAUSS, J | 1 |
Howe, HE; Sladek, CD; Somponpun, SJ | 1 |
Flynn, FW; Haley, GE | 2 |
1 review(s) available for hydralazine and pituitrin
Article | Year |
---|---|
[Mechanism of development and principles of treatment of malignant arterial hypertension].
Topics: Adrenergic beta-Antagonists; Anemia, Hemolytic; Animals; Antihypertensive Agents; Cyclic AMP; Factor XII; Humans; Hydralazine; Hypertension, Malignant; Labetalol; Platelet Aggregation; Prostaglandins F; Rabbits; Rats; Renin-Angiotensin System; Thromboplastin; Vasopressins; Water-Electrolyte Imbalance | 1983 |
14 other study(ies) available for hydralazine and pituitrin
Article | Year |
---|---|
Baroreceptor-mediated release of vasopressin in patients with chronic congestive heart failure and defective sympathetic responsiveness.
Topics: Adult; Aged; Cardiac Catheterization; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Norepinephrine; Pressoreceptors; Renin; Sympathetic Nervous System; Vasopressins | 1992 |
Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arginine; Blood Pressure; Hydralazine; In Vitro Techniques; Male; Nitrates; Nitric Acid; Nitric Oxide; Nitroarginine; omega-N-Methylarginine; Penicillamine; Phenylephrine; Rats; Rats, Inbred Strains; S-Nitroso-N-Acetylpenicillamine; Sympathetic Nervous System; Vasodilation; Vasopressins | 1991 |
Atrial natriuretic factor-induced systemic vasoconstriction in conscious dogs, rats, and monkeys.
Topics: Adrenergic alpha-Antagonists; Animals; Atrial Natriuretic Factor; Consciousness; Dogs; Hemodynamics; Hydralazine; Macaca; Macaca fascicularis; Nitroglycerin; Prazosin; Rats; Rats, Inbred Strains; Renin; Vasoconstriction; Vasopressins | 1990 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins | 1991 |
Antianginal effects of the new calcium antagonist benidipine hydrochloride in anesthetized rats and spontaneously hypertensive rats. Electrocardiographic study.
Topics: Angina Pectoris; Animals; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Electrocardiography; Heart Rate; Hydralazine; Isoproterenol; Male; Nifedipine; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Vasopressins | 1988 |
Non-specific inhibition of pressor agents in vivo by the renin inhibitor pepstatin A.
Topics: Animals; Blood Pressure; Captopril; Female; Hydralazine; Oligopeptides; Pepstatins; Phenylephrine; Rats; Rats, Inbred Strains; Renin; Swine; Time Factors; Vasopressins | 1984 |
Liminal therapy: a strategy for the complete and selective destruction of malignant tissue in situ.
Topics: Animals; Antineoplastic Agents; Cell Survival; Dihydralazine; Drug Resistance; Energy Metabolism; Humans; Hydralazine; Isoproterenol; Mice; Naphazoline; Neoplasms; Oxygen; Oxygen Consumption; Phenylephrine; Sarcoma, Experimental; Time Factors; Vasopressins | 1984 |
Decreases in arterial pressure activate oxytocin neurons in conscious rats.
Topics: Animals; Antihypertensive Agents; Avoidance Learning; Blood Pressure; Chlorisondamine; Conditioning, Psychological; Hydralazine; Hypotension; Hypothalamus; Male; Neurons; Oxytocin; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Saccharin; Taste; Vasopressins | 1997 |
Oxytocin antagonist disrupts hypotension-evoked renin secretion and other responses in conscious rats.
Topics: Animals; Diazoxide; Heart Rate; Hormone Antagonists; Hydralazine; Hypotension; Kinetics; Male; Oxytocin; Rats; Rats, Sprague-Dawley; Renin; Vasodilator Agents; Vasopressins; Vasotocin | 2001 |
Antihypertensive drugs induce structural remodeling of the penile vasculature.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Enalapril; Hydralazine; Male; Methoxamine; Penis; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins; Ventricular Remodeling | 2001 |
KIDNEY OXYGEN AVAILABILITY.
Topics: Amobarbital; Anesthesia; Anesthesia, Spinal; Arginine Vasopressin; Bone Marrow; Carbon Dioxide; Cats; Epinephrine; Erythropoiesis; Hydralazine; Kidney; Metabolism; Methacholine Compounds; Nitrogen; Oxygen; Pharmacology; Polarography; Research; Vascular Surgical Procedures; Vasopressins | 1963 |
Role of neurokinin 3 receptors in supraoptic vasopressin and oxytocin neurons.
Topics: Acetates; Animals; Catecholamines; Cell Compartmentation; Cell Nucleus; Cytoplasm; Endosomes; Hydralazine; Hypotension; Hypothalamo-Hypophyseal System; Hypothalamus, Anterior; Male; Microinjections; Microscopy, Confocal; Neurons; Oxytocin; Peptide Fragments; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled; Receptors, Neurokinin-1; Receptors, Neurokinin-3; Substance P; Tachykinins; Transcription, Genetic; Tryptophan; Vasopressins | 2004 |
Tachykinin NK3 receptor contribution to systemic release of vasopressin and oxytocin in response to osmotic and hypotensive challenge.
Topics: Animals; Hydralazine; Hypotension; Hypothalamus; Infusions, Intravenous; Injections, Intraventricular; Male; Osmotic Pressure; Oxytocin; Quinolines; Rats; Receptors, Neurokinin-3; Sodium Chloride; Vasodilator Agents; Vasopressins; Water-Electrolyte Balance | 2007 |
Blockade of NK3R signaling in the PVN decreases vasopressin and oxytocin release and c-Fos expression in the magnocellular neurons in response to hypotension.
Topics: Animals; Blood Pressure; Cell Nucleus; Hydralazine; Hypotension; Hypothalamus, Anterior; Immunohistochemistry; Male; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Quinolines; Rats; Rats, Inbred Strains; Receptors, Neurokinin-3; Signal Transduction; Vasopressins | 2008 |